hVIVO is in pole position to capitalise on increasing interest in human challenge trials
HVIVO (HVO:AIM) 28.2pMarket cap: £191.9 millionFluCamp does not sound like much fun for volunteers, but for leading CRO (contract research organisation) HVIVO (HVO:AIM) it represents a flagship service which is attracting growing...
19 September 2024